Worst-Case Value-At-Risk and Robust Portfolio Optimization: A Conic Programming Approach
L. Ghaoui, Maksim Oks, F. Oustry
semanticscholar +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Construction and predictive value of risk models of maternal serum alpha-fetoprotein variants and fetal open neural tube defects. [PDF]
Chen Y +8 more
europepmc +1 more source
PENERAPAN METODE MEAN CONDITIONAL VALUE AT RISK PADA PORTOFOLIO BLACK-LITTERMAN [PDF]
Ni Luh Putu Rian Sumariska +1 more
openalex
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Clinical value and risk factors of compression supporting screwsin patients with femoral neck fractures. [PDF]
Zhang Y +5 more
europepmc +1 more source
Value-at-Risk Prediction: A Comparison of Alternative Strategies
Keith Kuester +2 more
semanticscholar +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
A case study of the informative value of risk of bias and reporting quality assessments for systematic reviews. [PDF]
Leenaars CHC +3 more
europepmc +1 more source

